Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-17-012348

Senior Vice President and CFO gave up 12,308 shares (to pay taxes)

  • Senior Vice President and CFO acquired 36,455 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

STAAB THOMAS R II · Senior Vice President and CFO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2017-03-16 Exercise or conversion : show line 1 in the form +23,955 $3.78 $90,550 141,268 D
2017-03-16 Exercise or conversion : show line 2 in the form +12,500 $1.42 $17,750 153,768 D
2017-03-16 Shares withheld for taxes : show line 3 in the form −12,308 $8.80 $108,310 141,460 D

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2017-03-16 Exercise or conversion : show line 4 in the form Emp. Stock Option (Right to Buy) −23,955 $3.78 2021-07-01 23,955 59,055 D
2017-03-16 Exercise or conversion : show line 5 in the form Emp. Stock Option (Right to Buy) −12,500 $1.42 2023-01-01 12,500 75,000 D
Loading xslF345X03/form4.xml…